Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2009-06-04 Transaction in Own Shar…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Board of Directors Approved a New Share Repurchase Program 3 pages ?Kb
Transaction in Own Shares Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 29, 2009, by ResMed Inc. The key content is the announcement of a new share repurchase program authorizing the company to buy back up to 10 million shares of its common stock. This is a clear update on the company's capital structure and financing activities. The document does not contain financial statements or detailed financial analysis but announces a capital action. According to the filing definitions, announcements about share repurchase programs fall under 'Transaction in Own Shares' (POS). The document length is under 5,000 characters and is not merely an announcement of a report publication but a substantive announcement of a capital activity. Therefore, the correct classification is POS with high confidence.
2009-06-04 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Daily share buy-back notice' and references Appendix 3E, which is a standard form used for reporting on-market share buy-back activities to the ASX. It contains details about the number of shares bought back, total consideration paid, and compliance statements. The document is short (2287 characters) and focuses on reporting a share repurchase event rather than providing comprehensive financial data or analysis. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buyback activities. There is no indication that this is an announcement of a report publication or a regulatory filing unrelated to share transactions. Therefore, the correct classification is POS.
2009-06-04 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Daily share buy-back notice' and references Appendix 3E, which is a standard form for reporting on-market share buy-back activities to the ASX. It contains details about the number of shares bought back, total consideration paid, participation by directors, and compliance statements. The document length is short (2301 characters) and it is a specific notice about share repurchase activity rather than a full financial report or announcement of a report. This fits the definition of a Transaction in Own Shares (POS) filing, which reports the company's buyback of its own shares.
2009-05-31 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to an on-market buy-back of shares by ResMed Inc. It provides details about the number of shares bought back, total consideration paid, participation by directors, and compliance statements. The document is a regulatory notice about share repurchase activity rather than a full financial report or announcement of a new report. It fits the description of a 'Transaction in Own Shares' filing, which covers company buy-back or sale of its own shares. The document length is short and focused solely on buy-back details, confirming it is not an annual or interim report, nor a general regulatory filing or announcement of a report publication.
2009-05-28 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to an on-market buy-back of shares by ResMed Inc. It provides details about the number of shares bought back, total consideration paid, participation by directors, and compliance statements. The document is short (2299 characters) and focuses on reporting a share repurchase activity. It does not contain comprehensive financial statements or detailed financial analysis, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a regulatory announcement about voting, management changes, or legal proceedings. The content clearly fits the category of a report on the company's own share transactions (buy-back). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2009-05-27 English
RESMED INC. TO PRESENT AT UPCOMING CONFERENCES IN JUNE 1
Investor Presentation Classification · 90% confidence The document is a short announcement about upcoming presentations by ResMed Inc. at various investor conferences. It mentions dates, times, and locations of presentations and provides information on how to access the webcast. There is no detailed financial data, no report attached or published, and no regulatory filing or certification. The content fits the description of an Investor Presentation announcement rather than the presentation materials themselves. Given the length and content, it is best classified as an Investor Presentation (IP) announcement.
2009-05-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.